Akshay K. Vaishnaw

2018

In 2018, Akshay K. Vaishnaw earned a total compensation of $2.6M as President, Research and Development at Alnylam Pharmaceuticals, a 186% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$228,000
Option Awards$1,801,063
Salary$570,000
Other$20,608
Total$2,619,671

Vaishnaw received $1.8M in option awards, accounting for 69% of the total pay in 2018.

Vaishnaw also received $228K in non-equity incentive plan, $570K in salary and $20.6K in other compensation.

Rankings

In 2018, Akshay K. Vaishnaw's compensation ranked 4,457th out of 14,244 executives tracked by ExecPay. In other words, Vaishnaw earned more than 68.7% of executives.

ClassificationRankingPercentile
All
4,457
out of 14,244
69th
Division
Manufacturing
1,668
out of 5,759
71st
Major group
Chemicals And Allied Products
598
out of 2,122
72nd
Industry group
Drugs
499
out of 1,811
72nd
Industry
Pharmaceutical Preparations
388
out of 1,385
72nd
Source: SEC filing on April 2, 2021.

Vaishnaw's colleagues

We found four more compensation records of executives who worked with Akshay K. Vaishnaw at Alnylam Pharmaceuticals in 2018.

2018

John Maraganore

Alnylam Pharmaceuticals

Chief Executive Officer

2018

Barry Greene

Alnylam Pharmaceuticals

Former President

2018

Yvonne Greenstreet

Alnylam Pharmaceuticals

Chief Operating Officer

2018

Laurie Keating

Alnylam Pharmaceuticals

Chief Legal Officer

News

In-depth

You may also like